Use of insulin to increase epiblast cell number: towards a new approach for improving ESC isolation from human embryos
Files
(Published version)
Date
2013
Authors
Campbell, J.
Lane, M.
Vassiliev, I.
Nottle, M.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
BioMed Research International, 2013; 2013:1-7
Statement of Responsibility
Jared M. Campbell, Michelle Lane, Ivan Vassiliev, and Mark B. Nottle
Conference Name
Abstract
Human embryos donated for embryonic stem cell (ESC) derivation have often been cryopreserved for 5–10 years. As a consequence, many of these embryos have been cultured in media now known to affect embryo viability and the number of ESC progenitor epiblast cells. Historically, these conditions supported only low levels of blastocyst development necessitating their transfer or cryopreservation at the 4–8-cell stage. As such, these embryos are donated at the cleavage stage and require further culture to the blastocyst stage before hESC derivation can be attempted. These are generally of poor quality, and, consequently, the efficiency of hESC derivation is low. Recent work using a mouse model has shown that the culture of embryos from the cleavage stage with insulin to day 6 increases the blastocyst epiblast cell number, which in turn increases the number of pluripotent cells in outgrowths following plating, and results in an increased capacity to give rise to ESCs. These findings suggest that culture with insulin may provide a strategy to improve the efficiency with which hESCs are derived from embryos donated at the cleavage stage.
School/Discipline
Dissertation Note
Provenance
Description
Access Status
Rights
Copyright © 2013 Jared M. Campbell et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.